# Bidirectional Mendelian Randomization Analysis for Vitamin D and Thyroid Peroxidase Antibody

Authors: Yingchao Chen; Bing Han; Chunfang Zhu; Qin Li; Chi Chen; Hualing Zhai; Ningjian Wang; Yi Chen; Yingli Lu
Journal: International Journal of Endocrinology
 (2022)

---

## Abstract

Purpose. Whether Vitamin D deficiency or insufficiency is associated with thyroid autoimmunity was debated for long time. This study was still to explore the causal relationship of 25 (OH) D with a thyroid peroxidase antibody (TPOAb). Methods. The data were obtained from a cross-sectional study, SPECT-China study, which was performed in 23 sites in East China during 2014 to 2016. 10636 participants were finally included in this study. Genotyped four 25 (OH) D-related and four TPOAb-associated single nucleotide polymorphisms (SNPs) created their genetic risk scores (GRS). Bidirectional mendelian randomization (MR) analysis was used in this study. Results. 25 (OH) D GRS was significantly associated with 25 (OH) D (B −0.093, 95% CI −0.111, −0.074) and TPOAb level (B 0.067, 95% CI 0.002 to 0.132). TPOAb GRS was significantly associated with TPOAb concentration (B 0.345, 95% CI 0.135 to 0.556), but not 25 (OH) D (B −0.030, 95% CI −0.091 to 0.030). Using 25 (OH) D_GRS as instrumental variable in the MR analysis, a causal relationship of genetically determined 25 (OH) D with increased TPOAb concentration (B −0.720, 95% CI −1.429 to −0.012). No relation was found between genetically instrumented TPOAb and 25 (OH) D. Conclusion. A higher VD_GRS was associated with higher risk of increased TPOAb concentration, which supports a causal association between decreased vitamin D and increased concentration of TPOAb in an eastern Chinese population.


---

## Body

## 1. Introduction

Thyroid dysfunction including overt and subclinical hypothyroidism in the population has considerable consequences for a number of health issues, including insulin resistance, metabolic syndrome, worse lipid profile, central adiposity, and obesity [1–4]. The most common cause of hypothyroidism is the Hashimoto thyroiditis (HT) and the basic mechanisms in the development of thyroid autoimmunity may be due to a combined TPO- and Tg-specific cytotoxic immune response [5]. It was reported that the prevalence of detectable thyroid antibodies, primarily TPOAb, comprises 10–12% of the healthy population [6–8]. Despite the prevalence and adverse outcomes of autoimmune-mediated thyroid disease, its etiology remains incompletely understood [9, 10].Vitamin D deficiency is also a pandemic health problem in both developing and developed countries [11]. Recently, the actions of vitamin D have been shown to go beyond calcium/phosphorus homeostasis via bone formation and resorption to higher susceptibilities of immune-mediated disorders, including chronic infections and autoimmune diseases [12]. Several epidemiological studies showed lower vitamin D levels to the pathogenesis of increasing TPOAb [6, 13–17]. However, conflicting studies were also present reporting that no significant association between the serum vitamin D levels and thyroid autoimmunity [18–20]. Thus, whether low vitamin D levels truly associated with AITD, whether the association is causal, and if so, its causal direction, is still unclear.The Mendelian randomization (MR) approach was taken widely used for assessing causality in population studies [21], which is the main limitation of a cross-sectional study. Using the genetic variants as the instrumental variable (IV) has become a widely-used approach for causal inference [22]. In this study, if low 25 (OH) D causally induces high TPOAb, genetic variants associated with lower 25 (OH) D should be associated with higher TPOAb concentration, and vice versa. These genetic variants are inherited independent of potential confounding factors [22]. Thus, MR could avoid problems in conventional epidemiological studies such as residual confounding and reverse causation [23].In the present study, on the basis of the large community-based sample of Chinese participants from SPECT-China study (Survey on Prevalence in East China for metabolic diseases and risk factors), we performed a bidirectional MR approach to explore the causal association between increased TPOAb levels and decreased 25 (OH) D levels. TPOAb and Vitamin D genetic risk scores (TPOAb_GRS and VD_GRS) were constructed to represent the genetic susceptibility.


## 2. Materials and Methods

### 2.1. Study Participants

The data were from the SPECT-China study (ChiCTR1900021356), which is a large cross-sectional study. Recruitment and enrollment of the study have been previously described in detail [24–26]. From 2014 to 2016, 12666 subjects who were Chinese citizens, ≥18 years old, and had lived in their current area for ≥6 months were recruited for the SPECT-China study from 23 sites in Shanghai, Zhejiang, Jiangsu, Anhui, and Jiangxi Province. Among them, genotype information was available in 10672 participants (84.3%). We excluded the participants who missed information on more than two single nucleotide polymorphism (SNP) genotypes (n = 20), missing the concentration of TPOAb (n = 14) and 25 (OH) D (n = 2). 10636 participants were involved in the final analysis. All participants provided written informed consent before data collection. The study protocol was approved by the Ethics Committee of Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.


### 2.2. Measurements

A single assessment protocol of interview and collection of biological specimens at each site was undertaken. Blood samples of each participant were obtained from 7 : 00 Am to 10 : 00 Am after fasting for at least 8 hours. Blood samples were refrigerated immediately after phlebotomy, and after 2∼4 hours they were centrifugation and the serum was aliquoted and frozen in a central laboratory. TPOAb was measured by the chemiluminescence immunoassay (Siemens, immulite 2000, Erlangen, Germany) and the 25 (OH) D was detected using a chemiluminescence assay (Siemens ADVIA Centaur XP, Germany). Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared.


### 2.3. Genotyping, Genetic Loci Selection, and Genetic Risk Score Construction

DNA was extracted from blood white cells using a blood genomic DNA extraction kit (DP603, TIANGEN BIOTECH CO, LTD, Beijing, China) on an automated nucleic acid extraction instrument (YOSE-S32, TIANGEN BIOTECH CO, LTD, Beijing, China). Specific assays were designed using the Geneious Pro (v4.8.3) (https://www.geneious.com/). Mass determination was carried out with the JUNO and data acquisition was used Fluidigm SNP Genotyping Analysis v4.1.3 software (Fluidigm Corporation, South San Francisco, California, USA). Call rates of all SNPs were higher than 98% [27, 28].We selected 4 SNPs involved in susceptibility of TPOAb concentration (major histocompatibility complex, class II, DP beta 1 (HLA-DPB1)- rs9277555, thyroid peroxidase (TPO)- rs11675434, arginine-glutamic acid dipeptide repeats (RERE)- rs301799, and HLA complex P5 (HCP5)- rs3094228) for our analysis based on previously published genome-wide association study on TPOAb concentration [29]. We also selected 4 vitamin D-related SNPs (vitamin D binding protein (GC)- rs2282679, cytochrome P450 family 2 subfamily R member 1 (CYP2R1)- rs10741657, 7-dehydrocholesterol reductase (DHCR7)- rs12785878, and cytochrome P450 family 24 subfamily A member 1 (CYP24A1)-rs6013897) were chosen on the basis of the recent genome-wide association study on 25 (OH) D [30]. They all reached a genome-wide significance level (P<5×10−8) and not in linkage disequilibrium (r2 = 0).


### 2.4. Statistical Analysis

Data were analyzed by using IBM SPSS Statistics, Version 22 (IBM Corporation, Armonk, NY, USA). All analyses were two-sided. AP value <0.05 was considered significant. Continuous variables were expressed as the mean (±standard deviation) values, and categorical variables were presented as percentages. 25 (OH) D and TPOAb was logarithmically transformed before analysis.The additive genetic model for each SNP (coded as 0, 1 and 2) was used to construct GRS. For the VD_GRS, we created a weighted score by multiplying each SNP by a weight based on its effect size with 25 (OH) D obtained from a large study containing Asian population [30]. For the TPOAb_GRS, the weights were from meta-analysis of Atherosclerosis Risk In Communities study (ARIC) and Study of Health in Pomerania-TREND (SHIP) [29]. The characteristics of each SNP in the VD_GRS and TPOAb_GRS are summarized in Table 1.Table 1
Information of each SNP in GRS.
GeneChromosomePositionSNPEffect alleleEAFX2P For HWEVitamin D-related SNPsGC471742666rs2282679G0.320.02>0.05CYP2R11114893332rs10741657G0.641.58>0.05DHCR71171456403rs12785878G0.551.04>0.05CYP24A12054125940rs6013897A0.167.610.005<P<0.01TPOAb-related SNPsHLA-DPB1633087828rs9277555G0.494.600.01<P<0.05TPO21404043rs11675434T0.310.94>0.05RERE18429242rs301799C0.170.28>0.05HCP5631462150rs3094228G0.157.310.005<P<0.01EAF, Effect allele frequency; GRS, gDQenetic risk score; HWE, Hardy-Weinberg equilibrium; SNP, Single nucleotide polymorphism.To examine the strength of the allele scores as instruments, the F-statistic was approximated from the proportion of variation in the respective phenotype (R2) explained by the allele score, (F − stat = (R2∗(n − 2))/(1 − R2)) [31].Linear regression analyses were used to determine the association of the two GRSs and TPOAb with 25 (OH) D, and the association of the two GRSs and 25 (OH) D with TPOAb. Model 1 adjusted for age, sex. Model 2 adjusted for terms in model 1. Model 2 adjusted for terms in model 1 and waist to hip ratio.Regarding the MR analysis, the weighted VD_GRS and weighted TPOAb_GRS were used as the instrumental variables (IV) estimators to measure the strength of the bi-directional causal relationship between 25 (OH) D and TPOAb concentration. The formal MR analyses to estimate the possible causal effect of 25 (OH) D on TPOAb (and vice versa) were conducted using the IV ratio method [22]. For the causal association of increased risk of TPOAb in relation to lower 25 (OH) D, the computational formula was β (VD-TPOAb) = β (VD_GRS-TPOAb) /βVD_GRS-25 (OH) D). In the opposite direction, the computational formula was βIV(TPOAb-VD) = βTPOAb_GRS-25 (OH) D/β(TPOAb_GRS-TPOAb). The model was the same as the above model 2, adjusting for age, sex, and waist to hip ratio. The standard error (SE) and confidence interval (CI) for the IV estimators was estimated by the delta method. The formulas are shown below:(1)SEIV=absβIVSEGRS_exposureβGRS_exposure2+SEGRS_outcomeβGRS_outcome2,95%CIIV=βIV±1.96×SEIV.To validate the genetic instruments, we assessed the associations between each individual SNP with 25 (OH) D and TPOAb, respectively. We also measured the potential pleotropic associations of each individual SNP and the GRSs with age, sex, BMI, and waist to hip ratio.


## 2.1. Study Participants

The data were from the SPECT-China study (ChiCTR1900021356), which is a large cross-sectional study. Recruitment and enrollment of the study have been previously described in detail [24–26]. From 2014 to 2016, 12666 subjects who were Chinese citizens, ≥18 years old, and had lived in their current area for ≥6 months were recruited for the SPECT-China study from 23 sites in Shanghai, Zhejiang, Jiangsu, Anhui, and Jiangxi Province. Among them, genotype information was available in 10672 participants (84.3%). We excluded the participants who missed information on more than two single nucleotide polymorphism (SNP) genotypes (n = 20), missing the concentration of TPOAb (n = 14) and 25 (OH) D (n = 2). 10636 participants were involved in the final analysis. All participants provided written informed consent before data collection. The study protocol was approved by the Ethics Committee of Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.


## 2.2. Measurements

A single assessment protocol of interview and collection of biological specimens at each site was undertaken. Blood samples of each participant were obtained from 7 : 00 Am to 10 : 00 Am after fasting for at least 8 hours. Blood samples were refrigerated immediately after phlebotomy, and after 2∼4 hours they were centrifugation and the serum was aliquoted and frozen in a central laboratory. TPOAb was measured by the chemiluminescence immunoassay (Siemens, immulite 2000, Erlangen, Germany) and the 25 (OH) D was detected using a chemiluminescence assay (Siemens ADVIA Centaur XP, Germany). Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared.


## 2.3. Genotyping, Genetic Loci Selection, and Genetic Risk Score Construction

DNA was extracted from blood white cells using a blood genomic DNA extraction kit (DP603, TIANGEN BIOTECH CO, LTD, Beijing, China) on an automated nucleic acid extraction instrument (YOSE-S32, TIANGEN BIOTECH CO, LTD, Beijing, China). Specific assays were designed using the Geneious Pro (v4.8.3) (https://www.geneious.com/). Mass determination was carried out with the JUNO and data acquisition was used Fluidigm SNP Genotyping Analysis v4.1.3 software (Fluidigm Corporation, South San Francisco, California, USA). Call rates of all SNPs were higher than 98% [27, 28].We selected 4 SNPs involved in susceptibility of TPOAb concentration (major histocompatibility complex, class II, DP beta 1 (HLA-DPB1)- rs9277555, thyroid peroxidase (TPO)- rs11675434, arginine-glutamic acid dipeptide repeats (RERE)- rs301799, and HLA complex P5 (HCP5)- rs3094228) for our analysis based on previously published genome-wide association study on TPOAb concentration [29]. We also selected 4 vitamin D-related SNPs (vitamin D binding protein (GC)- rs2282679, cytochrome P450 family 2 subfamily R member 1 (CYP2R1)- rs10741657, 7-dehydrocholesterol reductase (DHCR7)- rs12785878, and cytochrome P450 family 24 subfamily A member 1 (CYP24A1)-rs6013897) were chosen on the basis of the recent genome-wide association study on 25 (OH) D [30]. They all reached a genome-wide significance level (P<5×10−8) and not in linkage disequilibrium (r2 = 0).


## 2.4. Statistical Analysis

Data were analyzed by using IBM SPSS Statistics, Version 22 (IBM Corporation, Armonk, NY, USA). All analyses were two-sided. AP value <0.05 was considered significant. Continuous variables were expressed as the mean (±standard deviation) values, and categorical variables were presented as percentages. 25 (OH) D and TPOAb was logarithmically transformed before analysis.The additive genetic model for each SNP (coded as 0, 1 and 2) was used to construct GRS. For the VD_GRS, we created a weighted score by multiplying each SNP by a weight based on its effect size with 25 (OH) D obtained from a large study containing Asian population [30]. For the TPOAb_GRS, the weights were from meta-analysis of Atherosclerosis Risk In Communities study (ARIC) and Study of Health in Pomerania-TREND (SHIP) [29]. The characteristics of each SNP in the VD_GRS and TPOAb_GRS are summarized in Table 1.Table 1
Information of each SNP in GRS.
GeneChromosomePositionSNPEffect alleleEAFX2P For HWEVitamin D-related SNPsGC471742666rs2282679G0.320.02>0.05CYP2R11114893332rs10741657G0.641.58>0.05DHCR71171456403rs12785878G0.551.04>0.05CYP24A12054125940rs6013897A0.167.610.005<P<0.01TPOAb-related SNPsHLA-DPB1633087828rs9277555G0.494.600.01<P<0.05TPO21404043rs11675434T0.310.94>0.05RERE18429242rs301799C0.170.28>0.05HCP5631462150rs3094228G0.157.310.005<P<0.01EAF, Effect allele frequency; GRS, gDQenetic risk score; HWE, Hardy-Weinberg equilibrium; SNP, Single nucleotide polymorphism.To examine the strength of the allele scores as instruments, the F-statistic was approximated from the proportion of variation in the respective phenotype (R2) explained by the allele score, (F − stat = (R2∗(n − 2))/(1 − R2)) [31].Linear regression analyses were used to determine the association of the two GRSs and TPOAb with 25 (OH) D, and the association of the two GRSs and 25 (OH) D with TPOAb. Model 1 adjusted for age, sex. Model 2 adjusted for terms in model 1. Model 2 adjusted for terms in model 1 and waist to hip ratio.Regarding the MR analysis, the weighted VD_GRS and weighted TPOAb_GRS were used as the instrumental variables (IV) estimators to measure the strength of the bi-directional causal relationship between 25 (OH) D and TPOAb concentration. The formal MR analyses to estimate the possible causal effect of 25 (OH) D on TPOAb (and vice versa) were conducted using the IV ratio method [22]. For the causal association of increased risk of TPOAb in relation to lower 25 (OH) D, the computational formula was β (VD-TPOAb) = β (VD_GRS-TPOAb) /βVD_GRS-25 (OH) D). In the opposite direction, the computational formula was βIV(TPOAb-VD) = βTPOAb_GRS-25 (OH) D/β(TPOAb_GRS-TPOAb). The model was the same as the above model 2, adjusting for age, sex, and waist to hip ratio. The standard error (SE) and confidence interval (CI) for the IV estimators was estimated by the delta method. The formulas are shown below:(1)SEIV=absβIVSEGRS_exposureβGRS_exposure2+SEGRS_outcomeβGRS_outcome2,95%CIIV=βIV±1.96×SEIV.To validate the genetic instruments, we assessed the associations between each individual SNP with 25 (OH) D and TPOAb, respectively. We also measured the potential pleotropic associations of each individual SNP and the GRSs with age, sex, BMI, and waist to hip ratio.


## 3. Results

### 3.1. Association of Four 25 (OH) D-Related SNPs with 25 (OH) D and TPOAb

The associations of each individual 25 (OH) D-related SNP with ln-TPOAb are summarized in Figures1(a) and 1(b). In these four 25 (OH) D-related SNPs, two SNPs located at the GC (rs2282679) and DHCR7 (rs12785878) loci were significantly associated with the level of 25 (OH) D and none of them were significantly associated with the concentration of TPOAb.Figure 1
(a) Association of the four vitamin D-related SNPs with 25 (OH) D (lnVD). (b) Association of the four vitamin D-related SNPs with TPOAb concentration (lnTPOAb). (c) Association of the four TPOAb-related SNPs with TPOAb concentration (lnTPOAb). (d) Association of the four TPOAb-related SNPs with 25 (OH) D (lnVD). Data were presented as unstandardized coefficients and 95% confidence interval. The model was adjusted for age, sex, and waist to hip ratio.
(a)(b)(c)(d)


### 3.2. Association of Four TPOAb-Related SNPs with 25 (OH) D and TPOAb

The associations of each individual TPOAb-related SNP with ln-25 (OH) D are summarized in Figures1(c) and 1(d). In these four TPOAb-related SNPs, two SNPs located at the HLA-DPB1 (rs9277555) and TPO (rs11675434) loci were significantly associated with the level of TPOAb and none of them were significantly associated with the level of 25 (OH) D.


### 3.3. Pleiotropic Effects of SNPs and Weighted GRS

The association of these four 25 (OH) D-related SNPs and four TPOAb-related SNPs with major 25 (OH) D and TPOAb related confounders were calculated. Therefore, we measured the potential associations of the SNPs with age, waist to hip ratio, BMI, and sex distribution using an additive model. Unstandardized coefficients (standard error) and odds ratio (95% confidence interval) are summarized in Table2. None of these eight SNPs had pleiotropic effects (all P>0.05).Table 2
Association of each individual SNP with confounders.
SNPAgeWaist to hip ratioBMISexB (SE)PB (SE)PB (SE)POR (95% CI)PVitamin D-related SNPsrs22826790.185 (0.180)0.3060.000 (0.001)0.9160.023 (0.049)0.6380.983 (0.922, 1.049)−0.017rs10741657−0.011 (0.177)0.9510.000 (0.001)0.858−0.017 (0.048)0.7281.023 (0.960, 1.089)0.485rs127858780.210 (0.171)0.2190.000 (0.001)0.8350.025 (0.046)0.5850.957 (0.901, 1.018)0.162rs60138970.185 (0.226)0.412−0.001 (0.001)0.331−0.037 (0.061)0.5480.935 (0.863, 1.013)0.099Vitamin D-related SNPsrs92775550.165 (0.171)0.334−0.001 (0.001)0.3220.030 (0.046)0.5211.007 (0.948, 1.070)0.819rs11675434−0.120 (0.183)0.5120.002 (0.001)0.0830.031 (0.050)0.5291.014 (0.950, 1.083)0.676rs301799−0.144 (0.224)0.5210.001 (0.001)0.528−0.007 (0.061)0.9091.033 (0.953, 1.119)0.432rs30942280.415 (0.236)0.079−0.001 (0.001)0.6840.054 (0.064)0.3981.046 (0.961, 1.138)0.295Data are expressed as unstandardized coefficients (standard error) and odds ratio (95% confidence interval). Multiple linear and logistic regression was performed. The model was adjusted for age (not for age), sex (not for sex), and waist to hip ratio (not for BMI and waist to hip ratio).Then, the association of VD_GRS and TPOAb-GRS with major 25 (OH) D and TPOAb related confounders were calculated for further analysis (Table3). Neither of them has significant association with these confounders (all P>0.05).Table 3
Association of the GRSs with confounders.
VD_GRSTPOAb_GRSContinuous variableB (SE)PB (SE)PAge0.498 (0.346)0.1500.827 (1.123)0.462BMI−0.016 (0.101)0.8710.422 (0.328)0.199Waist to hip ratio0.000 (0.002)0.8080.003 (0.007)0.625Ln 25 (OH) D−0.093 (0.009)<0.001−0.030 (0.031)0.330lnTPOAb0.067 (0.033)0.0430.345 (0.107)0.001Categorical variableOR (95%CI)POR (95%CI)PSex0.931 (0.823, 1.054)0.2591.231 (0.823, 1.840)0.311Data are expressed as unstandardized coefficients (standard error) and odds ratio (95% confidence interval). Multiple linear and logistic regression was performed. The model was adjusted for age (not for age), sex (not for sex) and waist to hip ratio (not for BMI and waist to hip ratio).


### 3.4. Study Characteristics According to Weighted VD_GRS and TPOAb_GRS Tertiles

We classified study subjects into three groups according to VD_GRS tertiles (Q1: ≤0.82, Q2: 0.83–1.13, Q3: ≥1.14) and TPOAb_GRS tertiles (Q1: ≤0.136, Q2: 0.137–0.240, Q3: ≥0.241), respectively. The general characteristic of study subjects in terms of these two tertiles is shown in Table4. As expected, with the increasing of VD_GRS, 25 (OH) D concentrations significantly decreased and with the increasing of TPOAb_GRS, TPOAb concentrations significantly increased (P<0.001 and P=0.021). TPOAb concentrations increased significantly along with the increased VD_GRS levels (P=0.019). However, there is no significant difference of 25 (OH) D levels between TPOAb_GRS tertiles (P>0.05).Table 4
Characteristics of study participants according to the weighted vitamin D genetic risk score (VD_GRS) and weighted TPOAb_GRS (n = 10636).
CharacteristicsVD_GRSQ1Q2Q3P For trendVD_GRS≤0.820.83 – 1.13≥1.14N347736233536Age, years54.64 ± 13.0254.76 ± 12.9855.15 ± 12.690.219Male (%)39.240.740.00.439Smokers (%)19.120.920.60.146BMI (kg/m2)24.62 ± 3.4924.63 ± 3.6724.65 ± 3.590.941Waist to hip ratio0.86 ± 0.080.86 ± 0.080.86 ± 0.080.574SBP (mmHg)132.35 ± 21.24132.55 ± 21.72132.76 ± 21.690.73825 (OH) D (mmol/L)41.89 ± 13.2240.80 ± 12.7239.02 ± 11.96<0.001TPOAb (U/ml)108.45 ± 289.42113.84 ± 297.72121.46 ± 310.480.019TPOAb_GRSQ1Q2Q3P For trendTPOAb_GRS≤0.1360.137 – 0.240≥0.241N366038423134Age, years54.72 ± 13.2854.92 ± 12.6854.92 ± 12.710.750Male (%)40.940.038.90.252Smokers (%)20.720.119.90.719BMI (kg/m2)24.54 ± 3.5624.71 ± 3.6024.64 ± 3.610.126Waist to hip ratio0.86 ± 0.080.86 ± 0.080.86 ± 0.080.242SBP (mmHg)132.67 ± 21.62132.20 ± 21.41132.87 ± 21.640.41525 (OH) D (mmol/L)40.59 ± 12.5740.68 ± 12.8140.40 ± 12.930.435TPOAb (U/ml)104.67 ± 283.87119.49 ± 307.07120.24 ± 307.210.021The data are summarized as the mean ± SD for continuous variables or as a numerical proportion for categorical variables.P for trend was calculated by ANOVA and chi-square tests. 25 (OH) D, 25-hydroxyvitamin D; GRS, genetic risk score.


### 3.5. Associations of VD_GRS and 25 (OH) D with TPOAb Concentration

As shown in Table5, in this cross-sectional study, 25 (OH) D was positively associated with the level of TPOAb after adjusted for age, sex, and waist to hip ratio (B = 0.070, 95% CI 0.003, 0.017). Then, the association of VD_GRS and tertiles of VD_GRS with TPOAb concentration was measured. Increased VD_GRS was significantly associated with increased TPOAb levels after adjusting for age and sex (B = 0.066, 95% CI 0.002, 0.129) (model 1). Further adjusting for waist to hip ratio did not change the result (B = 0.067, 95% CI 0.002, 0.132) (model 2). The same trend was also seen in the tertiles of VD_GRS (P for trend = 0.027 in model 1 and 0.031 in model 2).Table 5
Associations of VD_GRS and 25 (OH) D with TPOAb concentration.
Model 1Model 2VD_GRS0.066 (0.002, 0.129)0.067 (0.002, 0.132)Tertiles of VD_GRSQ10.000 (ref)0.000 (ref)Q20.009 (−0.045, 0.062)0.007 (−0.047, 0.062)Q30.061 (0.007, 0.114)0.060 (0.006, 0.115)P For trend0.0270.03125 (OH) D0.069 (0.003, 0.135)0.070 (0.003, 0.137)Data were presented as and 95% confidence interval. 25 (OH) D, 25-hydroxyvitamin D; GRS, genetic risk score; Model 1 adjusted for age and sex; Model 2 adjusted for terms in model 1 and waist to hip ratio.


### 3.6. Associations of TPOAb_GRS and TPOAb with 25 (OH) D Concentration

Conversely, the association of the TPOAb_GRS and TPOAb with 25 (OH) D is shown in Table6. Although the TPOAb level was significantly associated with the level of 25 (OH) D, increased TPOAb_GRS was not significantly associated with decreased level of 25 (OH) D in both models. The tertiles of TPOAb_GRS showed similar results (both P for trend >0.05).Table 6
Associations of TPOAb_GRS and TPOAb concentration with 25 (OH) D.
Model 1Model 2TPOAb_GRS−0.031 (−0.090, 0.029)−0.030 (−0.091, 0.030)Tertiles of TPOAb_GRSQ10.000 (ref.)0.000 (ref.)Q20.003 (−0.012, 0.018)0.003 (−0.012, 0.018)Q3−0.005 (−0.021, 0.011)−0.005 (−0.021, 0.011)P For trend0.5710.586TPOAb0.006 (0.000, 0.011)0.006 (0.000, 0.011)Data were presented as and 95% confidence interval. 25 (OH) D, 25-hydroxyvitamin D; GRS, genetic risk score; Model 1 adjusted for age and sex; Model 2 adjusted for terms in model 1 and waist to hip ratio.


### 3.7. 25 (OH) D and TPOAb Concentration: The Bidirectional MR Analysis

In order to elevated the strength of the allele scores as instruments, F-statistic for VD_GRS and TPOAb_GRS was calculated. For VD_GRS, it was 85.76 and for TPOAb_GRS, it was 10.64. Figure2 shows the association of genetically determined 25 (OH) D with TPOAb concentration, and conversely, genetically determined TPOAb with 25 (OH) D concentrations. In the IV analysis, the causal regression coefficient of genetically determined 25 (OH) D for concentration of TPOAb was −0.720 (95% CI: −1.429, −0.012), and the causal regression coefficient of genetically determined TPOAb for 25 (OH) D was −0.087 (95% CI −0.271, 0.097).Figure 2
Bidirectional instrumental variable (IV) estimated association between 25 (OH) D and TPOAb (concentration) by weighted GRSs. Data were adjusted for age, sex, waist to hip ratio.


## 3.1. Association of Four 25 (OH) D-Related SNPs with 25 (OH) D and TPOAb

The associations of each individual 25 (OH) D-related SNP with ln-TPOAb are summarized in Figures1(a) and 1(b). In these four 25 (OH) D-related SNPs, two SNPs located at the GC (rs2282679) and DHCR7 (rs12785878) loci were significantly associated with the level of 25 (OH) D and none of them were significantly associated with the concentration of TPOAb.Figure 1
(a) Association of the four vitamin D-related SNPs with 25 (OH) D (lnVD). (b) Association of the four vitamin D-related SNPs with TPOAb concentration (lnTPOAb). (c) Association of the four TPOAb-related SNPs with TPOAb concentration (lnTPOAb). (d) Association of the four TPOAb-related SNPs with 25 (OH) D (lnVD). Data were presented as unstandardized coefficients and 95% confidence interval. The model was adjusted for age, sex, and waist to hip ratio.
(a)(b)(c)(d)


## 3.2. Association of Four TPOAb-Related SNPs with 25 (OH) D and TPOAb

The associations of each individual TPOAb-related SNP with ln-25 (OH) D are summarized in Figures1(c) and 1(d). In these four TPOAb-related SNPs, two SNPs located at the HLA-DPB1 (rs9277555) and TPO (rs11675434) loci were significantly associated with the level of TPOAb and none of them were significantly associated with the level of 25 (OH) D.


## 3.3. Pleiotropic Effects of SNPs and Weighted GRS

The association of these four 25 (OH) D-related SNPs and four TPOAb-related SNPs with major 25 (OH) D and TPOAb related confounders were calculated. Therefore, we measured the potential associations of the SNPs with age, waist to hip ratio, BMI, and sex distribution using an additive model. Unstandardized coefficients (standard error) and odds ratio (95% confidence interval) are summarized in Table2. None of these eight SNPs had pleiotropic effects (all P>0.05).Table 2
Association of each individual SNP with confounders.
SNPAgeWaist to hip ratioBMISexB (SE)PB (SE)PB (SE)POR (95% CI)PVitamin D-related SNPsrs22826790.185 (0.180)0.3060.000 (0.001)0.9160.023 (0.049)0.6380.983 (0.922, 1.049)−0.017rs10741657−0.011 (0.177)0.9510.000 (0.001)0.858−0.017 (0.048)0.7281.023 (0.960, 1.089)0.485rs127858780.210 (0.171)0.2190.000 (0.001)0.8350.025 (0.046)0.5850.957 (0.901, 1.018)0.162rs60138970.185 (0.226)0.412−0.001 (0.001)0.331−0.037 (0.061)0.5480.935 (0.863, 1.013)0.099Vitamin D-related SNPsrs92775550.165 (0.171)0.334−0.001 (0.001)0.3220.030 (0.046)0.5211.007 (0.948, 1.070)0.819rs11675434−0.120 (0.183)0.5120.002 (0.001)0.0830.031 (0.050)0.5291.014 (0.950, 1.083)0.676rs301799−0.144 (0.224)0.5210.001 (0.001)0.528−0.007 (0.061)0.9091.033 (0.953, 1.119)0.432rs30942280.415 (0.236)0.079−0.001 (0.001)0.6840.054 (0.064)0.3981.046 (0.961, 1.138)0.295Data are expressed as unstandardized coefficients (standard error) and odds ratio (95% confidence interval). Multiple linear and logistic regression was performed. The model was adjusted for age (not for age), sex (not for sex), and waist to hip ratio (not for BMI and waist to hip ratio).Then, the association of VD_GRS and TPOAb-GRS with major 25 (OH) D and TPOAb related confounders were calculated for further analysis (Table3). Neither of them has significant association with these confounders (all P>0.05).Table 3
Association of the GRSs with confounders.
VD_GRSTPOAb_GRSContinuous variableB (SE)PB (SE)PAge0.498 (0.346)0.1500.827 (1.123)0.462BMI−0.016 (0.101)0.8710.422 (0.328)0.199Waist to hip ratio0.000 (0.002)0.8080.003 (0.007)0.625Ln 25 (OH) D−0.093 (0.009)<0.001−0.030 (0.031)0.330lnTPOAb0.067 (0.033)0.0430.345 (0.107)0.001Categorical variableOR (95%CI)POR (95%CI)PSex0.931 (0.823, 1.054)0.2591.231 (0.823, 1.840)0.311Data are expressed as unstandardized coefficients (standard error) and odds ratio (95% confidence interval). Multiple linear and logistic regression was performed. The model was adjusted for age (not for age), sex (not for sex) and waist to hip ratio (not for BMI and waist to hip ratio).


## 3.4. Study Characteristics According to Weighted VD_GRS and TPOAb_GRS Tertiles

We classified study subjects into three groups according to VD_GRS tertiles (Q1: ≤0.82, Q2: 0.83–1.13, Q3: ≥1.14) and TPOAb_GRS tertiles (Q1: ≤0.136, Q2: 0.137–0.240, Q3: ≥0.241), respectively. The general characteristic of study subjects in terms of these two tertiles is shown in Table4. As expected, with the increasing of VD_GRS, 25 (OH) D concentrations significantly decreased and with the increasing of TPOAb_GRS, TPOAb concentrations significantly increased (P<0.001 and P=0.021). TPOAb concentrations increased significantly along with the increased VD_GRS levels (P=0.019). However, there is no significant difference of 25 (OH) D levels between TPOAb_GRS tertiles (P>0.05).Table 4
Characteristics of study participants according to the weighted vitamin D genetic risk score (VD_GRS) and weighted TPOAb_GRS (n = 10636).
CharacteristicsVD_GRSQ1Q2Q3P For trendVD_GRS≤0.820.83 – 1.13≥1.14N347736233536Age, years54.64 ± 13.0254.76 ± 12.9855.15 ± 12.690.219Male (%)39.240.740.00.439Smokers (%)19.120.920.60.146BMI (kg/m2)24.62 ± 3.4924.63 ± 3.6724.65 ± 3.590.941Waist to hip ratio0.86 ± 0.080.86 ± 0.080.86 ± 0.080.574SBP (mmHg)132.35 ± 21.24132.55 ± 21.72132.76 ± 21.690.73825 (OH) D (mmol/L)41.89 ± 13.2240.80 ± 12.7239.02 ± 11.96<0.001TPOAb (U/ml)108.45 ± 289.42113.84 ± 297.72121.46 ± 310.480.019TPOAb_GRSQ1Q2Q3P For trendTPOAb_GRS≤0.1360.137 – 0.240≥0.241N366038423134Age, years54.72 ± 13.2854.92 ± 12.6854.92 ± 12.710.750Male (%)40.940.038.90.252Smokers (%)20.720.119.90.719BMI (kg/m2)24.54 ± 3.5624.71 ± 3.6024.64 ± 3.610.126Waist to hip ratio0.86 ± 0.080.86 ± 0.080.86 ± 0.080.242SBP (mmHg)132.67 ± 21.62132.20 ± 21.41132.87 ± 21.640.41525 (OH) D (mmol/L)40.59 ± 12.5740.68 ± 12.8140.40 ± 12.930.435TPOAb (U/ml)104.67 ± 283.87119.49 ± 307.07120.24 ± 307.210.021The data are summarized as the mean ± SD for continuous variables or as a numerical proportion for categorical variables.P for trend was calculated by ANOVA and chi-square tests. 25 (OH) D, 25-hydroxyvitamin D; GRS, genetic risk score.


## 3.5. Associations of VD_GRS and 25 (OH) D with TPOAb Concentration

As shown in Table5, in this cross-sectional study, 25 (OH) D was positively associated with the level of TPOAb after adjusted for age, sex, and waist to hip ratio (B = 0.070, 95% CI 0.003, 0.017). Then, the association of VD_GRS and tertiles of VD_GRS with TPOAb concentration was measured. Increased VD_GRS was significantly associated with increased TPOAb levels after adjusting for age and sex (B = 0.066, 95% CI 0.002, 0.129) (model 1). Further adjusting for waist to hip ratio did not change the result (B = 0.067, 95% CI 0.002, 0.132) (model 2). The same trend was also seen in the tertiles of VD_GRS (P for trend = 0.027 in model 1 and 0.031 in model 2).Table 5
Associations of VD_GRS and 25 (OH) D with TPOAb concentration.
Model 1Model 2VD_GRS0.066 (0.002, 0.129)0.067 (0.002, 0.132)Tertiles of VD_GRSQ10.000 (ref)0.000 (ref)Q20.009 (−0.045, 0.062)0.007 (−0.047, 0.062)Q30.061 (0.007, 0.114)0.060 (0.006, 0.115)P For trend0.0270.03125 (OH) D0.069 (0.003, 0.135)0.070 (0.003, 0.137)Data were presented as and 95% confidence interval. 25 (OH) D, 25-hydroxyvitamin D; GRS, genetic risk score; Model 1 adjusted for age and sex; Model 2 adjusted for terms in model 1 and waist to hip ratio.


## 3.6. Associations of TPOAb_GRS and TPOAb with 25 (OH) D Concentration

Conversely, the association of the TPOAb_GRS and TPOAb with 25 (OH) D is shown in Table6. Although the TPOAb level was significantly associated with the level of 25 (OH) D, increased TPOAb_GRS was not significantly associated with decreased level of 25 (OH) D in both models. The tertiles of TPOAb_GRS showed similar results (both P for trend >0.05).Table 6
Associations of TPOAb_GRS and TPOAb concentration with 25 (OH) D.
Model 1Model 2TPOAb_GRS−0.031 (−0.090, 0.029)−0.030 (−0.091, 0.030)Tertiles of TPOAb_GRSQ10.000 (ref.)0.000 (ref.)Q20.003 (−0.012, 0.018)0.003 (−0.012, 0.018)Q3−0.005 (−0.021, 0.011)−0.005 (−0.021, 0.011)P For trend0.5710.586TPOAb0.006 (0.000, 0.011)0.006 (0.000, 0.011)Data were presented as and 95% confidence interval. 25 (OH) D, 25-hydroxyvitamin D; GRS, genetic risk score; Model 1 adjusted for age and sex; Model 2 adjusted for terms in model 1 and waist to hip ratio.


## 3.7. 25 (OH) D and TPOAb Concentration: The Bidirectional MR Analysis

In order to elevated the strength of the allele scores as instruments, F-statistic for VD_GRS and TPOAb_GRS was calculated. For VD_GRS, it was 85.76 and for TPOAb_GRS, it was 10.64. Figure2 shows the association of genetically determined 25 (OH) D with TPOAb concentration, and conversely, genetically determined TPOAb with 25 (OH) D concentrations. In the IV analysis, the causal regression coefficient of genetically determined 25 (OH) D for concentration of TPOAb was −0.720 (95% CI: −1.429, −0.012), and the causal regression coefficient of genetically determined TPOAb for 25 (OH) D was −0.087 (95% CI −0.271, 0.097).Figure 2
Bidirectional instrumental variable (IV) estimated association between 25 (OH) D and TPOAb (concentration) by weighted GRSs. Data were adjusted for age, sex, waist to hip ratio.


## 4. Discussion

This investigation including 10636 community-dwelling Chinese adults, we examined whether these two GRSs, composed of SNPs significantly associated with genetically determined 25 (OH) D and genetically determined TPOAb concentration, were associated with increased TPOAb concentration and decreased 25 (OH) D level, respectively. Using the bidirectional MR study design, we found a causal role of vitamin D in the pathogenesis of increasing TPOAb level, while no causal relationship of higher TPOAb concentration to induce lower vitamin D status was found. To the best of our knowledge, for the first time, the results provided novel evidence for a causal relationship between genetically determined Vitamin D and increased TPOAb concentration by using MR. The identification of a causal relationship between 25 (OH) D and TPOAb concentration may have important clinical implications because vitamin D deficiency is common, and vitamin D supplementation is relatively safe and cost-effective [32].The MR approach has an important benefit that it helps to overcome problems of confounding and reverse causality, which limits the ability to draw causal inferences in non-genetic observational studies [22]. However, several assumptions should be well met in performing a MR analysis [33–35]. First, the GRS as an IV was strongly associated with the exposure of interest. All SNPs used in this study have previously been shown to be significantly associated with vitamin D or TPOAb concentration in large meta-analysis of GWAS [29, 30]. In the present study, the associations of these two GRSs with the two corresponding exposures were also very significant. Second, the IVs must not be correlated with any confounders of the exposure-outcome association. In our study, we found the two GRSs were not associated with age, BMI, waist to hip ratio, and sex which were common potential confounders of the vitamin D-TPOAb association. We further tested the pleiotropic effects of each SNP on the above confounders and the results showed no SNP had pleiotropic effects. Third, the IV related to outcome only through the exposure of interest. There should be no direct effect of genotype on disease or any other mediated effectors other than through the exposure of interest. Thus, we analyzed the association of each SNP and GRSs with the corresponding outcome (vitamin D or TPOAb). All the SNPs and GRSs were not significantly associated with the outcome.Recently, in a nationwide population-based study, data were obtained from the Korea National Health and Nutrition Examination Survey VI-1 and 2 (2013 and 2014) showed that the higher TPOAb level was more prevalent in the vitamin D-deficient group and vitamin D deficiency affects thyroid autoimmunity and dysfunction in iodine-replete area [36]. In our present study, we found that higher VD_GRS, presenting a low 25 (OH) D level, had a significantly negative association with higher TPOAb, providing strong evidence in support of a causal role of decreased vitamin D on increased TPOAb. These findings are consistent with evidence from observational studies that have demonstrated that low vitamin D levels influence risk of an increasing TPOAb level, and also in line with a very current case-control study which enrolled 200 euthyroid subjects: 100 newly diagnosed HT patients and 100 healthy individuals, matched for age, sex, and BMI, which aimed to investigate the association of HT with vitamin D status and SNPs of the vitamin D receptor (VDR). It first suggested that vitamin D deficiency may contribute to HT development and/or progression, acting as an environmental trigger [37].Further, very limited intervention studies testing the effect of vitamin D supplementation on patients with AITD/HT showed that vitamin D supplements decreased TPOAb concentration, in those with vitamin D deficiency or those with normal vitamin D status [38, 39]. However, another randomized, double-blind, controlled trial (RCT) suggested Vitamin D3 supplementation did not affect the TPOAb level [40]. It should be noted that there exists an important difference between MR studies and RCTs. MR studies assess the association of a lifetime of exposure in the general population, whereas RCTs provide insights from supplementation for shorter periods in individuals at risk [41]. Thus, long-term RCTs may be needed to assess the role of vitamin D supplementation on the treatment of increased TPOAb adequately. The results from our study provides rationale to further investigate whether vitamin D supplementation may reduce AITDs susceptibility. The identification of vitamin D as a causal susceptibility factor for TPOAb may have important public health implications since vitamin D insufficiency/deficiency is common [11, 42], and vitamin D supplementation is both relatively safe and cost-effective [41].The strength of our study included a relatively large sample size (more than 10 000 participants), well-defined community setting, and a highly homogeneous population. To our acknowledgment, this is the first report exploring the causal association between low vitamin D and high TPOAb concentration using the bidirectional MR study design, creating VD_GRS and TPOAb_GRS, representing the established common genetic variants of vitamin D and TPOAb level used as the IV.However, several limitations should be acknowledged. First, it should be noted that the TPOAb_GRS we created in this study only for TPOAb concentration, not representing TPOAb positivity. Further studies were needed to explore the causal association between TPOAb positivity and vitamin D. Second, all participants were of were Han Chinese, a majority ethnic group indigenous within China (constitute about 92% of the population of the People’s Republic of China). The findings of this study may not be generalizable other ethnicities. Third, 25 (OH) D was measured only once at baseline. Hence, we were not able to control intraindividual variability. Fourth, we build up our GRSs only based on common variants, which were considered to represent limited TPOAb and vitamin D heritability. We were unable to assess the potential contribution of rare variants.


## 5. Conclusion

We found that a higher VD_GRS was associated with higher risk of increased TPOAb concentration. This analysis provides evidence supporting a causal association between decreased vitamin D and increased concentration of TPOAb in an eastern Chinese population. Additional studies are needed to validate our findings and elucidate the mechanisms behind these findings.



---

*Source: 2260388-2022-04-01.xml*